VIRTUALMAN and Hughes Biotechnology accelerates R&D innovations

Drug Discovery |  News | 0 Comment | 09 Mar, 2021

In an era when consumers are demanding more from producers for better, faster, and stronger products, the biotechnology ...Read more

Boehringer Ingelheim to develop innovative Peptides to treat Obesity

Drug Discovery |  News | 0 Comment | 01 Mar, 2021

Boehringer Ingelheim and Gubra on March, 1st 2021 announced a new research and licensing agreement focused on ...Read more

HitGen, UPPTHERA collaborate for drug discovery research

Drug Discovery |  News | 0 Comment | 02 Mar, 2021

Chinese firm HitGen has announced that it has entered into a drug discovery research collaboration with UPPTHERA Inc to ...Read more

Insilico Medicine discovers industry first preclinical drug candidate using AI

Drug Discovery |  News | 0 Comment | 25 Feb, 2021

China based Insilico Medicine has demonstrated a breakthrough in Artificial Intelligence ("AI") and drug disco...Read more

China's Suntrap discovers LeSoleil to fight COVID-19 and future epidemics

Drug Discovery |  News | 0 Comment | 15 Feb, 2021

AI-assisted computing has greatly improved the efficiency of new drug research and development. China's Suntrap Life Tec...Read more

The Next-generation antimalarial treatment designed to tackle the drug-resistance challenge

Drug Discovery |  Opinion | 0 Comment | 09 Feb, 2021

Since the previous century, Tropical and subtropical regions have been grappling under the parasitic...Read more

Korea approves first anti-COVID-19 monoclonal antibody treatment

Drug Discovery |  News | 0 Comment | 08 Feb, 2021

Celltrion Group has announced that the Ministry of Food and Drug Safety (MFDS) of South Korea has granted conditional ma...Read more

India's Biocon Biologics to offer Oncology Biosimilars in over 30 countries

Drug Discovery |  News | 0 Comment | 05 Feb, 2021

Biocon Biologics Ltd., a fully integrated ‘pure-play’ biosimilars company and a subsidiary of Bioc...Read more

Hong Kong develops formula for treating Alzheimer's disease

Drug Discovery |  News | 0 Comment | 05 Feb, 2021

Researchers from the School of Chinese Medicine (SCM) at Hong Kong Baptist University (HKBU) have developed a ...Read more

Genesis Medtech collaborates with Penumbra to expand Neurovascular market in China

Drug Discovery |  News | 0 Comment | 20 Jan, 2021

Genesis MedTech Group has reached a consensus to fully acquire Hua Medtech as part of its plans to set up a specialise...Read more

Mitsubishi Tanabe & Takeda to accelerate data-driven drug discovery

Drug Discovery |  News | 0 Comment | 19 Jan, 2021

Japanese firm Mitsubishi Tanabe Pharma Corporation (MTPC) has announced that MTPC and Takeda Pharmaceutical Company...Read more

Sosei and PharmEnable enter technology collaboration for AI-driven drug discovery

Drug Discovery |  News | 0 Comment | 12 Jan, 2021

Sosei Group Corporation (Sosei Heptares) in Japan and PharmEnable, a UK drug discovery company, have announced...Read more

Fujifilm injects $2B into large-scale cell culture manufacturing site in US

Drug Discovery |  News | 0 Comment | 08 Jan, 2021

FUJIFILM Corporation is making an investment of more than 200 Billion yen ($2 Billion) to establish a new...Read more

Y-Biologics, 3D Medicines collaborate to develop novel cancer therapeutics for China

Drug Discovery |  News | 0 Comment | 06 Jan, 2021

The South Korean biotech company Y-Biologics and the China-based biopharmaceutical company 3D Medicines have entere...Read more

Singapore launches spin-off to develop treatment for intractable diseases

Drug Discovery |  News | 0 Comment | 24 Dec, 2020

The Experimental Drug Development Centre (EDDC), a national platform for drug discovery and development hosted by A*STAR...Read more

Antengene submits NDAs for XPOVIO (Selinexor) in multiple APAC markets

Drug Discovery |  News | 0 Comment | 04 Dec, 2020

Antengene Corporation Limited, a leading innovative biopharmaceutical company dedicated to discovering, developing and c...Read more

Eisai and Wren Therapeutics collaborate for potential treatment of synucleinopathies

Drug Discovery |  News | 0 Comment | 01 Dec, 2020

Japanese firm Eisai Co., Ltd. and US based Wren Therapeutics Ltd. have announced that the companies have entered into an...Read more

Korea's OliPass advisory board to evaluate osteoarthritis pain killer drug development

Drug Discovery |  News | 0 Comment | 25 Nov, 2020

OliPass Corporation, a South Korea based biotech specialized in the development of RNA therapeutics, announced...Read more